Anti-PSGL1/CD162 Antibody (Neihulizumab)
Catalog No.
F1062
Anti-PSGL1/CD162 Antibody (Neihulizumab)
Featured Products
Neihulizumab (ALTB-168) is an immune checkpoint agonist antibody that binds to humanCD162 (PSGL-1)Neihulizumab is being investigated in steroid-refractory acute graft-versus-host disease (SR-aGVHD), psoriasis, psoriatic arthritis, and ulcerative colitis.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.72 kDa
Dry ice
2158362-38-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ALTB-168, AbGn-168H
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q14242
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human PSGL1 / CD162 HEK293T Cell Line were stained with Anti-PSGL1/CD162 Antibody (Neihulizumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS.
PSGL1 / CD162
Please avoid freeze-thaw cycles.